Detalles de la búsqueda
1.
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med
; 387(2): 109-119, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731908
2.
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
N Engl J Med
; 386(8): 713-723, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021004
3.
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med
; 386(20): 1899-1909, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353976
4.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep
; 73(8): 168-174, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421935
5.
Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using Capture-Recapture.
J Infect Dis
; 2023 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768170
6.
Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020.
Clin Infect Dis
; 76(3): e1031-e1039, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35867698
7.
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children.
Clin Infect Dis
; 76(3): e280-e290, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717646
8.
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
Clin Infect Dis
; 76(3): e90-e100, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924406
9.
The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness.
Pediatr Crit Care Med
; 24(12): 998-1009, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539964
10.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
J Infect Dis
; 226(5): 797-807, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385875
11.
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
Clin Infect Dis
; 75(2): 230-238, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35024795
12.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(2): 52-58, 2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025852
13.
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 264-270, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176002
14.
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
J Infect Dis
; 224(5): 813-820, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33378531
15.
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
Clin Infect Dis
; 73(12): 2240-2247, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34050659
16.
Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016.
Emerg Infect Dis
; 27(5): 1505-1508, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900183
17.
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(42): 1483-1488, 2021 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673751
18.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956782
19.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
20.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524